JASPER™ Robotic Surgery Platform
High-precision robotic platform for ophthalmic surgery leveraging robotics, advanced visualization, and cognitive data analytics
Device · On PremiseCompany source
Company profile
About ForSight Robotics
ForSight Robotics is transforming ophthalmic surgery through its JASPER™ Robotic Surgery Platform, which fuses robotics and artificial intelligence to address one of the largest global healthcare crises. The platform leverages high-precision robotics with micron-level accuracy, advanced 3D visualization and image guidance, and cognitive data analytics to enhance surgeon performance and elevate patient care. With 14 degrees of freedom and features like no-fly zones for safety, the system is designed to treat cataracts, glaucoma, and retinal diseases affecting the front and back segments of the eye. The company's mission centers on eradicating preventable blindness by augmenting human surgical capabilities, shortening learning curves, standardizing procedures, and improving ergonomics to extend surgeon careers. ForSight Robotics made history by performing the world's first fully robot-assisted cataract surgery in humans. The platform addresses the critical shortage of ophthalmologists globally (31.7 per million population) and aims to increase patient access to high-quality eye care. By reducing physical strain on surgeons and enabling more consistent outcomes, JASPER™ seeks to bridge the growing gap between the 600 million cataract patients worldwide and the limited surgical capacity. The company has assembled a team of experts in robotics, AI, and ophthalmology, supported by strategic and clinical advisory boards, to bring this transformative technology to market.
Company description ForSight Robotics official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at ForSight Robotics?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Age-related macular degeneration (AMD)
- Cataract
- Diabetic retinopathy
- Glaucoma
- Retinal detachment
- Retinal diseases
Who it serves
- Eye surgery centers
- Health Systems
- Ophthalmic surgeons
Deployment & integration
On Premise deployment with recorded integration context.
Geographic context
MarketsGlobal
Company sourceOfficial website
Company milestones
Platform expansion
Completed world's first-in-human fully robot-assisted cataract surgery. Raised $125 million in funding (second-largest fundraise for a surgical robotics firm).
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
JASPER™ Robotic Surgical System (Formerly Known as the ORYOM™ Robotic Surgical System) in Cataract SurgeryNCT07468409 · Sponsor · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Micron-level precision
Enhances microsurgical precision beyond human hand tremor limitations
Shortened learning curve
Empowers more surgeons to reach peak performance faster with precision guidance and real-time feedback
Standardized procedures
Introduces highly consistent approach that reduces outcome variability
Increased patient access
Enables surgeons to save intraoperative time and treat significantly more patients
Extended surgeon careers
Reduces musculoskeletal disorders through ergonomic design
Asian Eye Institute
World's first fully robot-assisted cataract surgery performed in a human patient
First-in-human fully robot-assisted cataract surgery completed from start to finish without general anesthesia
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from ForSight Robotics
Recent articles published on ForSight Robotics's official website.
How Deep Tech Can Transform Surgery
Read on ForSight RoboticsForSight Robotics Demonstrates Fully Robotic-Assisted Cataract Surgery Within the Standard Clinical Workflow of the World's Most Commonly Performed Surgical Procedure
Read on ForSight Robotics“Father of Surgical Robotics” Dr. Fred Moll Joins ForSight Robotics Board of Directors
Read on ForSight RoboticsForSight Robotics: Interview With Co-Founder, President, And Chief Medical Officer Dr. Joseph Nathan About Revolutionizing Ophthalmology With Surgical Robotics
Read on ForSight RoboticsWatch: World's First Fully Robot-Assisted In-Human Cataract Procedure
Read on ForSight Robotics07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.